News | July 21, 2014

Texas' First Accredited Pediatric Heart Failure Institute Is Texas Children's Hospital

July 21, 2014 – The Healthcare Accreditation Colloquium announced that Texas Children's Hospital has earned the designation of Accredited Pediatric Heart Failure Institute following 12 months of work and an extensive onsite review. 
 
"The approach to heart failure at Texas Children's Hospital is one of the broadest ranging comprehensive programs in the U.S.," said Dr. Frank Smart, Colloquium Board Chair. "They care for the sickest children daily, yet remain committed to breakthrough research that has the potential to change medicine for everyone." 
 
The heart failure leadership team at Texas Children's Hospital worked in four domains to achieve heart failure accreditation: The Community, Hospital, Clinician, and Science. In the community their preventative screening program for sudden cardiac arrest in young people was especially notable. The hospital itself is an integrated small city where pediatric patients can actually go to an accredited classroom for their schooling while on ventricular assist devices and after heart transplantation. In the Clinician Domain, physician and nurse education is part of the institutional culture. Novel approaches to practical applications of science are everywhere. One example is the "Just in Time" scenario room where world-class clinicians can come together and practice possible clinical scenarios to prepare themselves anticipating emergencies before they take place.
 
"The Colloquium is about bringing together experts to improve heart failure care for children across the entire continuum of care," said Dr. Daniel J. Penny, chief of cardiology at Texas Children's Hospital. "We are delighted that Texas Children's is a recognized member of this expert group. We look forward to working with The Colloquium wherever children with heart failure have a need." 
 
The Colloquium is the first organization to develop an improvement science based approach to pediatric heart failure accreditation. Member hospitals conduct the site visits following the guidelines developed by all member hospitals, making the Colloquium's approach to accreditation unique in America. The site reviewers were Frank W. Smart, MD, FACC, (Colloquium Board Chair) and Sonja H. Dahl, DNP, RN, CPNP, (Heart Failure Leadership Team Coordinator at Mayo Clinic in Rochester, Minnesota). 
 
For more information, visit: http://colloquiumhealth.com/

Related Content

EMPRISE Study Shows Empagliflozin Reduces Heart Failure Hospitalization with new data presented at AHA 2018. #AHA18 #AHA2018
News | Heart Failure | November 07, 2018
November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) s
Acute Heart Failure Mortality, Rehospitalizations Reduced With Blood Volume Measurement
News | Heart Failure | November 02, 2018
In a new study, acute heart failure patients who received individualized treatment by blood volume measurement with the...
Daxor Corp. Collaborating With CHF Solutions on Heart Failure Fluid Overload Management

CHF Solutions' Aquadex FlexFlow System

News | Heart Failure | November 01, 2018
November 1, 2018 — Daxor Corp.
NHLBI Pauses CONCERT-HF Heart Failure Trial
News | Heart Failure | October 29, 2018
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is pausing the...
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

Feature | Heart Failure | October 19, 2018
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S
Ohio State First in U.S. to Test Shunt Device for Heart Failure
News | Heart Failure | October 04, 2018
The Ohio State University Wexner Medical Center is first in the country to test a new medical device designed to help...
Mitral Regurgitation Volume Reduced at One Year in REDUCE FMR Trial
News | Heart Failure | September 28, 2018
Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical trial showed a...
Cardiac Dimensions Randomizes First Patient in CARILLON Trial of Mitral Contour System
News | Heart Failure | September 20, 2018
Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal Trial.
Overlay Init